These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25943265)

  • 1. Nodules in scrotum. Manifestation of urothelial carcinoma.
    Arrabal-Polo MÁ; del Carmen Cano-García M; Fabiano P
    Int Urol Nephrol; 2015 Jul; 47(7):1155-6. PubMed ID: 25943265
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
    Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National University Hospital experience.
    Kim HS; Lee JS; Jeong CW; Kwak C; Kim HH; Ku JH
    Int Braz J Urol; 2015; 41(6):1067-79. PubMed ID: 26742963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of paclitaxel and cisplatin for advanced urothelial cancer.
    Burch PA; Richardson RL; Cha SS; Sargent DJ; Pitot HC; Kaur JS; Camoriano JK
    J Urol; 2000 Nov; 164(5):1538-42. PubMed ID: 11025699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case records of the Massachusetts General Hospital. Case 30-2009. A 77-year-old man with recurrent transitional-cell carcinoma of the ureter.
    Kaufman DS; McDougal WS; Harisinghani MG; Wu CL
    N Engl J Med; 2009 Sep; 361(13):1292-9. PubMed ID: 19776411
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
    Shirotake S; Kikuchi E; Tanaka N; Matsumoto K; Miyazaki Y; Kobayashi H; Ide H; Obata J; Hoshino K; Kaneko G; Hagiwara M; Kosaka T; Kanao K; Kodaira K; Hara S; Oyama M; Momma T; Miyajima A; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
    J Urol; 2015 Apr; 193(4):1122-8. PubMed ID: 25444957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
    Lerner SE; Blute ML; Richardson RL; Zincke H
    Mayo Clin Proc; 1996 Oct; 71(10):945-50. PubMed ID: 8820768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral ureteral inverted papilloma with synchronous transitional cell tumor of the bladder.
    Hoekx L; Wyndaele JJ
    Acta Urol Belg; 1998 Oct; 66(3):17-9. PubMed ID: 9864872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma.
    Jinzaki M; Kikuchi E; Akita H; Sugiura H; Shinmoto H; Oya M
    Int J Urol; 2016 Apr; 23(4):284-98. PubMed ID: 26750188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for advanced transitional cell carcinoma of the urothelium: cisplatin or carboplatin?
    Culine S
    Eur Urol; 2007 Jul; 52(1):9-10. PubMed ID: 17239527
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrascotal metastasis of bladder transitional cell carcinoma as initial presentation of the disease.
    Fragkoulis C; Papadopoulos G; Gkialas I; Ntoumas K
    J BUON; 2016; 21(6):1565-1566. PubMed ID: 28039727
    [No Abstract]   [Full Text] [Related]  

  • 12. Mobile thrombus in the ascending aorta following cisplatin-based chemotherapy.
    Moorjani N; Rubens M; Price S; DeSouza A
    J Card Surg; 2013 Jan; 28(1):48-9. PubMed ID: 23199294
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transitional cell carcinoma of the upper urinary tract. Role and diagnostic possibilities of computerized tomography in the field of integrated imaging].
    Valentini AL; Summaria V; Campioni P; Danza FM
    Radiol Med; 1993 May; 85(5):530-9. PubMed ID: 8327752
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.
    Ito Y; Kikuchi E; Tanaka N; Miyajima A; Mikami S; Jinzaki M; Oya M
    J Urol; 2011 May; 185(5):1621-6. PubMed ID: 21419429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and pathological studies of the urothelial tumors with inverted proliferation].
    Takeuchi H; Wakabayashi Y; Hayashida H; Ishida A; Konami T; Tomoyoshi T
    Hinyokika Kiyo; 1991 Mar; 37(3):221-7. PubMed ID: 2069102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Micropapillary variant of urothelial carcinoma of the ureter : a case report].
    Moriyama H; Yoshino T; Yonehara S
    Hinyokika Kiyo; 2013 Jan; 59(1):23-6. PubMed ID: 23412120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitional cell carcinoma of the ovary.
    Yazigi R; Sahid S; Gutiérrez J; Rodríguez T; Contreras L
    J Obstet Gynaecol; 2005 Oct; 25(7):725-6. PubMed ID: 16263559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case report of a patient with advanced pelvic and ureteral cancer whose primary lesion could be enucleated after cytoreduction by modified CAP regimen].
    Mikata N; Imao S; Katoh A; Horiuti D; Tanaka Y; Sasaki H; Hamasima T
    Gan No Rinsho; 1989 Dec; 35(15):1807-11. PubMed ID: 2481751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z; Dimopoulos MA; Kostakopoulos A; Karayiannis A; Sofras F; Zervas A; Giannopoulos A; Dimopoulos C
    J Urol; 1997 Aug; 158(2):408-11. PubMed ID: 9224313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.